Aldactone /00006201/


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 42.6%
Hypertension 23.5%
Depression 5.9%
Atrial Fibrillation 4.4%
Diabetes Mellitus 2.9%
Hepatitis B 2.9%
Myocardial Ischaemia 2.9%
Vitamin Supplementation 2.9%
Ascites 1.5%
Cardiac Failure 1.5%
Hypokalaemia 1.5%
Malnutrition 1.5%
Oedema Peripheral 1.5%
Peritonitis 1.5%
Thrombosis Prophylaxis 1.5%
Type 2 Diabetes Mellitus 1.5%
Agranulocytosis 9.1%
Hypertrophic Cardiomyopathy 9.1%
Hyponatraemia 9.1%
Hypotension 9.1%
Inappropriate Antidiuretic Hormone Secretion 9.1%
Oedema 9.1%
Prothrombin Level Decreased 9.1%
Renal Failure Acute 9.1%
Syncope 9.1%
Toxic Skin Eruption 9.1%
Vascular Purpura 9.1%
Concomitant
Product Used For Unknown Indication 63.3%
Hypertension 6.6%
Pain 5.4%
Prophylaxis 4.1%
Type 2 Diabetes Mellitus 2.3%
Hepatitis C 2.0%
Diabetes Mellitus 1.8%
Coronary Artery Disease 1.3%
Chronic Obstructive Pulmonary Disease 1.2%
Insulin-requiring Type Ii Diabetes Mellitus 1.2%
Oedema 1.2%
Pulmonary Arterial Hypertension 1.2%
Anxiety 1.1%
Back Pain 1.1%
Hypokalaemia 1.1%
Rheumatoid Arthritis 1.1%
Cardiac Failure Congestive 1.0%
Osteoporosis 1.0%
Angina Pectoris 0.9%
Asthma 0.9%
Vomiting 10.0%
Death 8.0%
Shock 8.0%
Oedema Peripheral 6.0%
Renal Failure 6.0%
Stenotrophomonas Infection 6.0%
Bradycardia 4.0%
Cardiac Failure 4.0%
Hypoglycaemia 4.0%
Injection Site Warmth 4.0%
Loss Of Consciousness 4.0%
Muscle Spasms 4.0%
Nausea 4.0%
Off Label Use 4.0%
Platelet Count Decreased 4.0%
Rash 4.0%
Renal Failure Acute 4.0%
Renal Tubular Necrosis 4.0%
Syncope 4.0%
Tendon Rupture 4.0%

Drug Data